Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes

Abstract

Bitter Melon (Momordica charantia) is a widely used traditional remedy for hyperglycemia. While the medicinal properties of this plant have been studied extensively using in vitro and animal models, the clinical efficacy and safety in humans is largely unknown. This review discusses the benefits and limitations of bitter melon supplementation in the context of epidemic levels of insulin resistance and pre-diabetes throughout the world. © 2014 by the authors; licensee MDPI, Basel, Switzerland.